Published in Biochemistry (Mosc) on January 01, 2013
Use of mesenchymal stem cells for therapy of cardiac disease. Circ Res (2015) 1.57
The biology and function of exosomes in cancer. J Clin Invest (2016) 1.04
Pancreatic cancer diagnosis by free and exosomal miRNA. World J Gastrointest Pathophysiol (2013) 0.89
MicroRNAs in stool samples as potential screening biomarkers for pancreatic ductal adenocarcinoma cancer. Am J Cancer Res (2014) 0.84
Inflammatory cytokines, interleukin-1 beta and tumor necrosis factor-alpha, upregulated in glioblastoma multiforme, raise the levels of CRYAB in exosomes secreted by U373 glioma cells. Biochem Biophys Res Commun (2014) 0.77
Exosomes in Cancer Diagnostics. Cancers (Basel) (2017) 0.75
The roles and implications of exosomes in sarcoma. Cancer Metastasis Rev (2016) 0.75
RNA Profiling Analysis of the Serum Exosomes Derived from Patients with Active and Latent Mycobacterium tuberculosis Infection. Front Microbiol (2017) 0.75
Mechanism of oligonucleotide uptake by cells: involvement of specific receptors? Proc Natl Acad Sci U S A (1989) 1.97
Complementary-addressed (sequence-specific) modification of nucleic acids. Prog Nucleic Acid Res Mol Biol (1985) 1.87
Health care, medical practice, and medical ethics in Russia today. JAMA (1995) 1.76
Tertiary structure of tRNAs in solution monitored by phosphodiester modification with ethylnitrosourea. Eur J Biochem (1981) 1.56
Synthesis of alkylating oligonucleotide derivatives containing cholesterol or phenazinium residues at their 3'-terminus and their interaction with DNA within mammalian cells. FEBS Lett (1989) 1.35
Cationic lipid-DNA complexes-lipoplexes-for gene transfer and therapy. Bioelectrochemistry (2002) 1.35
Cell-free and cell-bound circulating DNA in breast tumours: DNA quantification and analysis of tumour-related gene methylation. Br J Cancer (2006) 1.32
Isolation of ribosomal subunits containing intact rRNA from human placenta: estimation of functional activity of 80S ribosomes. Anal Biochem (1991) 1.18
Interaction of tRNAPhe and tRNAVal with aminoacyl-tRNA synthetases. A chemical modification study. Eur J Biochem (1983) 1.13
Nucleotide and oligonucleotide derivatives as enzyme and nucleic acid targeted irreversible inhibitors. Chemical aspects. Adv Enzyme Regul (1985) 1.06
Characterisation of membrane oligonucleotide-binding proteins and oligonucleotide uptake in keratinocytes. Nucleic Acids Res (1999) 0.98
Complementary addressed modification and cleavage of a single stranded DNA fragment with alkylating oligonucleotide derivatives. Nucleic Acids Res (1986) 0.98
RNase T1 mimicking artificial ribonuclease. Nucleic Acids Res (2007) 0.95
Site-specific cleavage of single-stranded DNAs at unique sites by a copper-dependent redox reaction. Nature (1988) 0.95
Studying functional significance of the sequence 980-1061 in the central domain of human 18S rRNA using complementary DNA probes. Biochim Biophys Acta (1997) 0.94
[Automated H-phosphonate synthesis of oligoribonucleotides using 2'-O-tetrahydropyranyl protective group]. Bioorg Khim (1990) 0.93
Synthetic RNA-cleaving molecules mimicking ribonuclease A active center. Design and cleavage of tRNA transcripts. Nucleic Acids Res (1993) 0.91
Sequence-specific chemical modification of a 365-nucleotide-long DNA fragment with an alkylating oligonucleotide derivative. FEBS Lett (1985) 0.90
Arrangement of mRNA at the decoding site of human ribosomes. 18S rRNA nucleotides and ribosomal proteins cross-linked to oligouridylate derivatives with alkylating groups at either the 3' or the 5' termini. Eur J Biochem (1994) 0.89
Structural arrangement of tRNA binding sites on Escherichia coli ribosomes, as revealed from data on affinity labelling with photoactivatable tRNA derivatives. Biochim Biophys Acta (1989) 0.89
Porphyrin-linked oligonucleotides. Synthesis and sequence-specific modification of ssDNA. FEBS Lett (1990) 0.89
Nucleotide and oligonucleotide derivatives as enzyme and nucleic acid targeted irreversible inhibitors. Biochemical aspects. Adv Enzyme Regul (1985) 0.86
The tertiary structure of yeast tRNAPhe in solution studied by phosphodiester bond modification with ethylnitrosourea. FEBS Lett (1980) 0.86
Reactive oligonucleotide derivatives and sequence-specific modification of nucleic acids. Biochimie (1986) 0.86
Chemical and computer probing of RNA structure. Prog Nucleic Acid Res Mol Biol (1996) 0.86
Protection of phosphodiester bonds in yeast tRNAVal by its cognate aminoacyl-tRNA synthetase against alkylation by ethylnitrosourea. FEBS Lett (1981) 0.86
Antisense oligonucleotide derivatives as gene-targeted drugs. Biomed Sci (1990) 0.85
Secondary structure of the 5'-region of PGY1/MDR1 mRNA. FEBS Lett (2000) 0.85
Hybridization of antisense oligonucleotides with the 3'part of tRNA(Phe). FEBS Lett (1999) 0.85
Cleavage of RNA with synthetic ribonuclease mimics. Methods Enzymol (2000) 0.85
Cleavage of RNA by an amphiphilic compound lacking traditional catalytic groups. Bioorg Chem (2007) 0.84
Immunoproteasome enhances intracellular proteolysis of myelin basic protein. Dokl Biochem Biophys (2014) 0.84
Cell membranes as barriers for antisense constructions. Antisense Res Dev (1992) 0.83
Structural arrangement of the decoding site of Escherichia coli ribosomes as revealed from the data on affinity labelling of ribosomes by analogs of mRNA--derivatives of oligoribonucleotides. Biochim Biophys Acta (1990) 0.83
Cleavage of yeast tRNAPhe with complementary oligonucleotide conjugated to a small ribonuclease mimic. FEBS Lett (2000) 0.83
[Downregulation of activated leukemic oncogenes AML1-ETO and RUNX1(K83N) expression with RNA-interference]. Mol Biol (Mosk) (2010) 0.83
Silencing of MDR 1 gene in cancer cells by siRNA. Nucleosides Nucleotides Nucleic Acids (2004) 0.81
Extracellular DNA in culture of primary and transformed cells, infected and not infected with mycoplasma. Bull Exp Biol Med (2009) 0.81
Identification of a site on 18 S rRNA of human placenta ribosomes in the region of the mRNA binding center. J Mol Biol (1990) 0.81
Experimental approach to study of the gonadotropin-releasing hormone function by knockdown of its expression with RNA interference in ontogenesis. Dokl Biol Sci (2009) 0.80
Artificial ribonucleases: oligonucleotide-peptide conjugates that cleave RNA at the GpX and PypA phosphodiester bonds. Dokl Biochem Biophys (2002) 0.80
Deoxyribonuclease activity in biological fluids of healthy donors and cancer patients. Bull Exp Biol Med (2008) 0.80
Alkylation of tRNATrp in a complex with tryptophanyl-tRNA synthetase. FEBS Lett (1978) 0.80
Reactive oligonucleotide derivatives as gene-targeted biologically active compounds and affinity probes. Genetica (1991) 0.80
[Synthetic ribonucleases. 1. Synthesis and properties of conjugates, containing an RNA-binding fragment based on lysine residues and an RNA hydrolyzing fragment, bearing an imidazole residue]. Bioorg Khim (1999) 0.80
[Affinity modification of 80S ribosomes from human placenta by derivatives of tri- and hexauridylates as mRNA analogs]. Mol Biol (Mosk) (1993) 0.79
Inhibition of HIV proliferation in MT-4 cells by antisense oligonucleotide conjugated to lipophilic groups. Biochimie (1993) 0.79
Expression of the MDR1 and MRP genes in patients with lymphoma with primary bone marrow involvement. Nucleosides Nucleotides Nucleic Acids (2004) 0.79
Interaction of oligonucleotides with barrier fluid proteins. Biochemistry (Mosc) (1997) 0.79
c-fos gene expression in cell revertants from a transformed to a pseudonormal phenotype. FEBS Lett (1993) 0.79
Functional topography of human ribosomes as studied by affinity labeling with reactive mRNA analogs. Biochimie (1992) 0.79
[Mechanism of oligonucleotide hybridization with the 3'-terminal region of yeast tRNA(Phe)]. Mol Biol (Mosk) (2000) 0.79
Cancer-suppressive effect of RNase A and DNase I. Dokl Biochem Biophys (2008) 0.78
Viral genome cleavage with artificial ribonucleases: a new method to inactivate RNA-containing viruses. Dokl Biochem Biophys (2009) 0.78
Rapid sequence-independent cellular response to oligodeoxynucleotides. FEBS Lett (1997) 0.78
Antiproliferative and interferon-inducing activities of unique short double-stranded RNA. Dokl Biochem Biophys (2011) 0.78
A Comparison of Target Gene Silencing using Synthetically Modified siRNA and shRNA That Express Recombinant Lentiviral Vectors. Acta Naturae (2009) 0.78
Ribonuclease activity of the peptides with alternating arginine and leucine residues conjugated to tetrathymidilate. Nucleosides Nucleotides Nucleic Acids (2004) 0.78
Structure of photoreactive binary system of oligonucleotide conjugates assembled on the target nucleotide sequence. J Biomol Struct Dyn (1999) 0.77
[Secondary structure of 5'-terminal region of mRNA of human multidrug resistance gene]. Mol Biol (Mosk) (2000) 0.77
Interaction of LNA oligonucleotides with mdr1 promoter. Nucleosides Nucleotides Nucleic Acids (2001) 0.77
[Site-specific cleavage of yeast tRNA(Phe) by derivatives of oligonucleotides bearing bisimidazole groups]. Dokl Akad Nauk (1999) 0.77
Involvement of the D-stem of tRNAPhe (E. coli) in interaction with phenylalanyl-tRNA synthetase as shown by chemical modification. FEBS Lett (1975) 0.77
Evidence from chemical modification for an unusual tertiary structure of the TpseudouridineC loop in rabbit liver tRNA1Val. FEBS Lett (1978) 0.77
[An RNA sequence determines the speed of its splitting by artificial ribonucleases]. Bioorg Khim (2010) 0.77
Serum immunoglobulins interact with oligonucleotides. FEBS Lett (1994) 0.77
Sequence-specific cleavage of single-stranded DNA by oligonucleotides conjugated to bleomycin. Antisense Res Dev (1992) 0.77
[Highly efficient site-directed RNA cleavage by imidazole-containing conjugates of antisense oligonucleotides]. Mol Biol (Mosk) (2002) 0.77
Structural studies by high-field NMR spectroscopy of a binary-addressed complementary oligonucleotide system juxtaposing pyrene and perfluoro-azide units. J Biomol Struct Dyn (1997) 0.77
Nuclear peptides specifically interacting with oligonucleotides. Nucleic Acids Symp Ser (1991) 0.77
[Unfolding of the tRNA(Phe) structure by complementary oligonucleotides]. Dokl Akad Nauk (1998) 0.76
[Cholesterol-modified anti-MDR1 small interfering RNA: uptake and biological activity]. Mol Biol (Mosk) (2010) 0.76
[Chemical ribonucleases. 3. Synthesis of organic catalysts of hydrolysis of phosphodiester bonds based on quaternary salts of 1,4-diazabicyclo(2.2.2)octane]. Bioorg Khim (2000) 0.76
Antitumor effect of the LIVP-GFP recombinant vaccinia virus. Dokl Biol Sci (2013) 0.76
Tumoricidal Activity of RNase A and DNase I. Acta Naturae (2010) 0.76
[Kinetic parameters of hydrolysis of CpA and UpA sequences in an oligoribonucleotide by compounds functionally mimicking ribonuclease A]. Mol Biol (Mosk) (2002) 0.76
Silencing of c-myc expression in tumor cells by siRNA. Nucleosides Nucleotides Nucleic Acids (2004) 0.75
Cancer incidence in USAF aircrew. Aviat Space Environ Med (1999) 0.75
New approaches for cancer treatment: antitumor drugs based on gene-targeted nucleic acids. Acta Naturae (2009) 0.75
Silencing of Her2, CCNB1 and PKC Genes by siRNA Results in Prolonged Retardation of Neuroblastoma Cell Division. Acta Naturae (2011) 0.75
[Antisense oligonucleotides inhibiting ribosomal functions in mycobacteria]. Izv Akad Nauk Ser Biol (2005) 0.75
[The use of RNAse H for digestion of alkylated 16S rRNA at the binding sites of addressed reagents--oligodeoxyribonucleotide derivatives]. Bioorg Khim (1990) 0.75
Novel amphiphilic compounds effectively inactivate the vaccinia virus. FEBS Lett (2012) 0.75
Formation of nucleosomes does not suppress interaction of a DNA fragment with an alkylating derivative of a pyrimidine oligonucleotide. Antisense Nucleic Acid Drug Dev (1999) 0.75
Refined high-field NMR solution structure of a binary-addressed pyrene/perfluoro-azide complementary DNA oligonucleotide system shows extensive distortion in the central nick region. J Biomol Struct Dyn (1999) 0.75
[mRNA-binding site of ribosomes at different stages of translation. II. Affinity modification of Escherichia coli ribosomes bya benzylidene derivative of AUGU6 in pre- and post-translation complexes]. Mol Biol (Mosk) (1988) 0.75
[Affinity modification of Escherichia coli ribosomes with 2',3'-O-[4-(N-2-chloroethyl)-N-methylamino]-benzylidene derivative of AUGU3 in the 70S initiation complexes]. Bioorg Khim (1988) 0.75